2-Chloro-N-(4-((5-(hydroxymethyl)-3-(4-phenoxyphenyl)-1H-pyrazol-1-yl)methyl)phenyl)acetamide

ID: ALA4444877

PubChem CID: 141741213

Max Phase: Preclinical

Molecular Formula: C25H22ClN3O3

Molecular Weight: 447.92

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CCl)Nc1ccc(Cn2nc(-c3ccc(Oc4ccccc4)cc3)cc2CO)cc1

Standard InChI:  InChI=1S/C25H22ClN3O3/c26-15-25(31)27-20-10-6-18(7-11-20)16-29-21(17-30)14-24(28-29)19-8-12-23(13-9-19)32-22-4-2-1-3-5-22/h1-14,30H,15-17H2,(H,27,31)

Standard InChI Key:  VAJNCPNDWPSXKS-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
    4.2084   -6.0979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8753   -6.5701    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5317   -6.0832    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2693   -5.3067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4530   -5.3195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8813   -7.3881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5933   -7.7865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7404   -4.6399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5552   -4.7156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0262   -4.0488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6837   -3.3059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8654   -3.2339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3980   -3.9016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1540   -2.6376    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9679   -2.7108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3076   -3.4561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1207   -3.5295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5919   -2.8608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2442   -2.1166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4321   -2.0468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4340   -6.3589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8207   -5.8187    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6006   -8.6009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3118   -8.9992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0138   -8.5818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0001   -7.7618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2884   -7.3671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7274   -8.9799    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7395   -9.7970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4532  -10.1951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0379  -10.2160    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4652  -11.0122    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  1  2  0
  6  7  1  0
  6  2  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  4  8  1  0
 11 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
  1 21  1  0
 21 22  1  0
  7 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27  7  1  0
 25 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  2  0
 30 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4444877

    ---

Associated Targets(Human)

Rec1 (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JeKo-1 (376 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Maver1 (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Z-138 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BTK Tclin Tyrosine-protein kinase BTK (8973 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 447.92Molecular Weight (Monoisotopic): 447.1350AlogP: 5.06#Rotatable Bonds: 8
Polar Surface Area: 76.38Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.49CX Basic pKa: 1.86CX LogP: 4.59CX LogD: 4.59
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.37Np Likeness Score: -1.31

References

1. Ran F, Liu Y, Zhang D, Liu M, Zhao G..  (2019)  Discovery of novel pyrazole derivatives as potential anticancer agents in MCL.,  29  (9): [PMID:30857748] [10.1016/j.bmcl.2019.03.005]

Source